Singapore markets closed

Biolidics Limited (8YY.SI)

SES - SES Delayed price. Currency in SGD
Add to watchlist
0.00900.0000 (0.00%)
At close: 11:39AM SGT
Show:
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Total revenue
272
1,315
2,489
2,314
8,907
-
Cost of revenue
115
594
1,326
1,831
5,468
-
Gross profit
157
721
1,163
483
3,439
-
Operating expenses
Research development
29
31
227
1,091
877.389
-
Selling general and administrative
-
-
-
-
-
2,066
Total operating expenses
1,740
1,957
4,198
3,795
4,017
-
Operating income or loss
-1,583
-1,236
-3,035
-3,312
-577.881
-
Interest expense
92
113
168
208
127.248
-
Income before tax
-2,905
-2,488
-9,850
-6,040
-4,684
-
Income tax expense
0
0
-476
-56
-33.009
-
Income from continuing operations
-2,905
-2,488
-9,374
-5,984
-4,651
-
Net income
-2,905
-2,488
-9,374
-5,984
-4,651
-
Net income available to common shareholders
-2,905
-2,488
-9,374
-5,984
-4,651
-
Basic EPS
-0.02
-
-0.03
-0.02
-0.02
-0.02
Diluted EPS
-0.02
-
-0.03
-0.02
-0.02
-0.02
Basic average shares
488,785
-
281,687
264,992
272,040
256,226
Diluted average shares
488,785
-
281,687
265,207
272,705
256,226